101692-02-8 Usage
Description
(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol is a complex organic compound with a unique molecular structure. It is characterized by its hexahydro-1H-benz[f]indene core, which is adorned with various hydroxyl and octyl groups. This molecule exhibits specific stereochemistry, with the R and S configurations at different carbon positions, which may influence its biological activity and interactions.
Uses
Used in Pharmaceutical Industry:
(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol is used as an active pharmaceutical ingredient for the treatment of pulmonary arterial hypertension (PAH). It serves as a synthetic analog of Prostacyclin, a naturally occurring compound with potent vasodilatory and antihypertensive properties. The compound is marketed under the trade name Remodulin, providing a therapeutic option for patients suffering from PAH.
Used in Chemical Synthesis:
In the field of chemical synthesis, (1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol can be utilized as a key intermediate or building block for the development of novel compounds with potential applications in various industries, such as pharmaceuticals, agrochemicals, and materials science. Its unique structural features may offer new opportunities for the design of innovative molecules with improved properties and functionalities.
Used in Research and Development:
As a complex organic molecule with specific stereochemistry, (1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol can be employed in research and development efforts to study its biological activities, interactions with biological targets, and potential applications in drug discovery. Understanding its properties and behavior can contribute to the advancement of scientific knowledge and the development of new therapeutic strategies.
Used in Drug Delivery Systems:
Similar to gallotannin, (1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol may also benefit from novel drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes. The development of carriers, such as organic and metallic nanoparticles, could improve the compound's efficacy and applicability in various medical conditions, including pulmonary arterial hypertension and other potential indications.
Check Digit Verification of cas no
The CAS Registry Mumber 101692-02-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,6,9 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 101692-02:
(8*1)+(7*0)+(6*1)+(5*6)+(4*9)+(3*2)+(2*0)+(1*2)=88
88 % 10 = 8
So 101692-02-8 is a valid CAS Registry Number.
101692-02-8Relevant articles and documents
Process for Preparing Treprostinil and Intermediate Therefor
-
, (2018/02/21)
The present invention relates to a synthesis method of high-purity treprostinil, and an intermediate for the same. According to the synthesis method of the present invention, high-purity treprostinil can be synthesized in an economical and efficient manner by using intramolecular Friedel-Crafts allylic alkylation. Accordingly, the synthesis method of the present invention may be effectively used for commercial mass-production of treprostinil.COPYRIGHT KIPO 2017
NOVEL INTERMEDIATE FOR SYNTHESIZING TREPROSTINIL DIETHANOLAMINE AND METHOD FOR PREPARING THE SAME
-
, (2016/06/28)
The present invention relates to a method for treprostinil diethanolamine synthesis. The present invention also relates to a novel intermediate used in the method for treprostinil diethanolamine synthesis. The novel intermediate is shown in the following formula (II): wherein R1 and R2 are described in the description.
AMINE SALTS OF A PROSTACYCLIN ANALOG
-
, (2015/06/03)
The present invention provides amine salts of the prostacyclin analogue of Formula I and processes for generating these amine salts.